Latest News - United Kingdom, Immunoglobulin

 
Show/hide duplicate news articles.
Filter by countryfromabout
<<10<12345678910>>>10
 
Show/hide duplicate news articles.
<<10<12345678910>>>10

Tools

Load latest edition

Saturday, April 20, 2024

6:22:00 PM Central European Summer Time

Subscribe
RSS
Subscribe
subscribe | manage
Subscribe
current page | all pages
Subscribe
info | definition

Language Selection

For any category/filter, users can choose:

  1. the language of the categorized news items (e.g. fr and de to display only those news items in French and German)
  2. the language of the user interface (e.g. it for Italian)

In Top Stories, the user can display the largest clusters of news items for one language only (e.g. en shows all clusters in English)

Country Selection

Users can choose:

  1. country mentioned in the news item (articles about a country)
  2. country in which the news item was published (articles from a country)

Languages Collapse menu...Expand menu...Open help...

Select your languages

ab
ar
az
be
bg
bs
ca
cs
da
de
el
en
eo
es
et
fa
fi
fo
fr
ga
gl
ha
he
hi
hr
hu
hy
id
is
it
ja
ka
km
ko
ku
ky
lb
lo
lt
lv
mk
ml
mn
ms
mt
my
na
ne
nl
no
ny
os
pap
pl
ps
pt
ro
ru
se
si
sk
sl
so
sq
sr
sv
sw
ta
th
tr
tt
uk
ur
vi
zh
zxx
all
Show additional languagesHide additional languages

Interface:

Select your country settings

Country info

GB

United Kingdom (GB)

All news about United Kingdom

All news sources from United Kingdom

GB

Quotes... Extracted quotes

Hari Narayanan says: “Britain’s warming climate means we all need to get used to an earlier start to the hay fever season and to prepare for new pollens from warmer climates, as new species of plants and trees move northwards. As species from warmer climes become established in the UK, more of us will become exposed to new pollens,”

yourweather Wednesday, April 17, 2024 at 6:28:00 PM Central European Summer Time

Levi Garraway said: “With a full year of data demonstrating near-complete suppression of relapse activity and minimal progression of lesion development, this 10-minute subcutaneous Ocrevus injection shows results that are consistent with the long-established benefits of intravenous Ocrevus,”

4-traders Wednesday, April 17, 2024 at 8:09:00 AM Central European Summer Time

Scott Newsome said: “Updated results from OCARINA II further underline the potential benefits of subcutaneous Ocrevus for patients with both relapsing and progressive forms of MS,”

4-traders Wednesday, April 17, 2024 at 8:09:00 AM Central European Summer Time

Hansa Biopharma said (about Hansa Biopharma): "I am very pleased to see the strong interest in the Hansa equity story from leading international healthcare specialist investors. This transaction will help finance the preparation of a potential U.S. launch of imlifidase in kidney transplantation, strengthen ongoing product development in autoimmune indications and allow for continued clinical development of HNSA-5487, the lead candidate from the NiceR program for repeat dosing"

4-traders Friday, April 12, 2024 at 3:43:00 AM Central European Summer Time

Most associated names

Alexia Putellas

Salma Paralluelo

Caroline Graham Hansen

Patri Guijarro

Champions League

Stephanie Frappart

BBC

Caroline Graham

Erin Cuthbert

EU

Daily number of articles in this category

Trend data not available for this selection.